Western Drug Makers Expand Use of India's Scientific Talent (India)
This article was originally published in PharmAsia News
India-based drug companies have been taking on pharmaceutical contracts from foreign partners for increasingly sophisticated research and drug discovery work, says Chemical & Engineering News head of the Asia-Pacific Bureau Jean-Francois Tremblay. Tremblay says this was particularly true beginning in 2005. India has a large pool of English-speaking scientists who are easy for global companies to work with. India also has a strong professional base of synthetic organic chemists who are highly motivated. (Click here for more
You may also be interested in...
Vibostolimab is less advanced than Roche’s competing tiragolumab, but Merck thinks the combo of its anti-TIGIT and Keytruda will offer a better therapeutic profile.
Ambitious efforts to make the EU more resilient to future challenges, such as health threats, drug supply problems, scientific advances and growing medicine costs, have taken a step forward with the publication of a roadmap for a wide-ranging Pharmaceutical Strategy to be adopted by the European Commission later in the year.
AdvaMed CEO Scott Whitaker shared a letter he sent to member companies voicing support for the ongoing protests around the US against police brutality that were sparked after the killing of George Floyd. “While we continue our single-minded pursuit of medical breakthroughs to treat and cure disease, we must also have a single-minded focus on eradicating the disease of racism in this country and around the world,” Whitaker wrote.